Keywords: elan/nobex, jv, starts, oral, calcitonin, trials, synerobex

Elan/Nobex JV starts oral calcitonin trials

Article | 15 April 2002

Print This

Synerobex, a joint venture formed by Nobex and Elan, has started aPhase I clinical trial in the development of Oratonin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in